The proteomic revolution

Gardado en:
Detalles Bibliográficos
Outros autores: Gold, Larry (Speaker)
Formato: Electrónico Video
Idioma:English
Publicado: London : Henry Stewart Talks, 2022.
Series:Henry Stewart talks. Biomedical & life sciences collection. Biomarkers.
Subjects:
Acceso en liña:https://hstalks.com/bs/2394/
Series
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

MARC

LEADER 00000cgm a2200000 a 4500
001 HST3398_1_3
003 UkLoHST
006 m c
007 cr|cna|||a||||
007 vz|czazum
008 220604s2022 enk|||||||||||s|||v|eng d
028 5 0 |a 3398  |b Henry Stewart Talks 
035 |a (UkLoHST)2394 
040 |a UkLoHST  |b eng  |c UkLoHST 
100 1 |a Gold, Larry.  |4 spk  |9 83308 
245 1 4 |a The proteomic revolution  |h [electronic resource] /  |c Larry Gold. 
260 |a London :  |b Henry Stewart Talks,  |c 2022. 
300 |a 1 online resource (1 streaming video file (55 min.) :  |b color, sound). 
490 1 |a Biomarkers : the path forward to highly sensitive and specific molecular diagnostics,  |x 2056-452X 
500 |a Animated audio-visual presentation with synchronized narration. 
500 |a Title from title frames. 
500 |a Updated version of a talk first published in 2012. 
505 0 |a Contents: The proteomic revolution -- Proteomics is the best measure of phenotype (biomarkers) -- Slow Off-rate Modified Aptamers (SOMAmers) are breakthrough protein binding reagents -- SOMAmers are multiplexed to perform SOMAscan assay, which measures >1000 proteins in small sample volumes using DNA measurement tools to identify and quantify proteins bound by SOMAmers -- Applications of SOMAscan to date include finding valid protein biomarkers for lung cancer, cardiovascular risk, pre-term birth, pancreatic cancer, mesothelioma, and many other diseases and conditions -- Ability to do comprehensive longitudinal proteomics studies will revolutionize medicine. 
506 |a Access restricted to subscribers. 
538 |a Mode of access: World Wide Web. 
650 0 |a Biochemical markers.  |9 83309 
650 0 |a Cancer  |x Diagnosis.  |9 83310 
650 0 |a Molecular diagnosis.  |9 83311 
650 0 |a Proteins  |x Analysis.  |9 83312 
650 0 |a Proteomics  |x Methodology.  |9 83313 
650 2 |a Biomarkers.  |9 83314 
650 2 |a Cardiovascular Diseases.  |9 83315 
650 2 |a DNA.  |9 83316 
650 2 |a Heart Disease Risk Factors.  |9 83317 
650 2 |a Lung Neoplasms  |x diagnosis.  |9 83318 
650 2 |a Mesothelioma  |x diagnosis.  |9 83319 
650 2 |a Molecular Diagnostic Techniques.  |9 83320 
650 2 |a Pancreatic Neoplasms  |x diagnosis.  |9 83321 
650 2 |a Pathology, Molecular.  |9 83322 
650 2 |a Protein Binding.  |9 83323 
650 2 |a Proteins  |x analysis.  |9 83324 
650 2 |a Proteomics  |x methods.  |9 83325 
650 2 |a Risk Factors.  |9 83326 
650 2 |a Term Birth.  |9 83327 
830 0 |a Henry Stewart talks.  |p Biomedical & life sciences collection.  |p Biomarkers.  |9 83328 
856 4 0 |u https://hstalks.com/bs/2394/ 
856 4 2 |u https://hstalks.com/bs/p/666/  |3 Series 
999 |c 213582  |d 213581